Tag: university

MARYSVILLE, Ohio, June 18, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that Nick Miaritis has been named executive vice president and chief brand officer, a new position overseeing the Company’s brands and leading all its marketing strategies and initiatives. The appointment represents a strategic pivot in the Company's SMG 2.0 transformation into a premier outdoor lifestyle brand.

LIVERMORE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Inertia Enterprises, the commercial fusion energy company, today announced the formation of its Science and Technology Advisory Board (STAB). The newly formed advisory board is an independent group of the world's foremost experts in fusion plasma physics, high-energy laser systems, large-scale program execution, target fabrication, and nuclear materials science. Its purpose is to provide rigorous, independent technical assessment across Inertia's physics, target, laser, and power plant development programs as the company prepares to deliver grid-scale fusion energy in the 2030s.

FREMONT, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced that it began production shipments of its IQ9S-3P™ Commercial Microinverter, the company's most powerful microinverter currently available across the United States. Built with advanced gallium nitride (GaN) technology, the IQ9S-3P Commercial Microinverter supports high-wattage solar panels up to 770 W and connects directly to three-phase 480Y/277 V (wye) grid configurations without requiring external transformers.

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for injection) followed by standard of care (SOC) in patients with invasive aspergillosis whose infection is either refractory to or unsuitable for azole therapy.

CALGARY, Alberta, June 17, 2026 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX: FRU) is pleased to announce the appointment of Brad Monaco as its Chief Financial Officer, effective June 22, 2026.